Granules recalls

FDA enforcement reports naming Granules USA, Inc. as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Sep 8, 2021

Severity

Sep 8, 2021Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, SyDrug · Granules USA, Inc.CGMP DeviationsClass II